What To Expect From ADC Therapeutics SA (ADCT) Q3 2024 Earnings [Yahoo! Finance]
ADC Therapeutics SA Common Shares (ADCT)
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $18.46 million, and the earnings are expected to come in at -$0.39 per share. The full year 2024's revenue is expected to be $72.90 million and the earnings are expected to be -$1.70 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 5 Warning Signs with ADCT. Over the past 90 days, revenue estimates for ADC Therapeutics SA ( NYSE:ADCT ) for the full year 2024 have slightly decreased from $72.92 million to $72.90 million, while the estimates for 2025 have increased from $83.07 million to $84.10 million. Earnings estimates for the full year 2024 have declined from -$1.69 per share to -$1.70 per share, and for 2025, they have decreased from -$1.45 per share to -$1.50 per share. In the previous quarter of 2024-06-30, ADC Therapeutics SA's ( NYSE:ADCT ) actual revenue was $17.41 million, which missed analysts' revenue expectations of $18.80 million by -7.38%. ADC Therapeutics SA's ( N
Show less
Read more
Impact Snapshot
Event Time:
ADCT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADCT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADCT alerts
High impacting ADC Therapeutics SA Common Shares news events
Weekly update
A roundup of the hottest topics
ADCT
News
- BerGenBio ASA (FRA:7BG0) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Leadership ... [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics Faces Competitive Oncology Market But Analyst Sees 100% Upside - Here's Why [Yahoo! Finance]Yahoo! Finance
- ADC Therapeutics Non-GAAP EPS of -$0.28, revenue of $18.46M misses by $0.04M [Seeking Alpha]Seeking Alpha
- ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational UpdatePR Newswire
- ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting [Yahoo! Finance]Yahoo! Finance
ADCT
Earnings
- 11/7/24 - Beat
ADCT
Sec Filings
- 11/14/24 - Form SC
- 11/13/24 - Form 8-K
- 11/13/24 - Form SC
- ADCT's page on the SEC website